Crosstalk between kisspeptin and gonadotropin-inhibitory hormone in the silence of puberty: preclinical evidence from a calcium signaling study

dc.contributor.authorBulut, Ferah
dc.contributor.authorKacar, Emine
dc.contributor.authorBilgin, Batuhan
dc.contributor.authorHekim, Munevver Gizem
dc.contributor.authorKelestemur, Muhammed Mirac
dc.contributor.authorSahin, Zafer
dc.contributor.authorOzcan, Mete
dc.date.accessioned2026-08-12T17:20:30Z
dc.date.issued2022
dc.departmentFırat Üniversitesi
dc.description.abstractKisspeptin and gonadotropin-inhibitory hormone (GnIH) are among suggested neuroendocrine modulators of reproductive function. Intracellular calcium signaling is a critical component in the regulation of a variety of physiological and pathological processes including neurotransmitter release, and, therefore, can be used as signaling indicator for investigating the involvement of kisspeptin, GnIH, and gonadotropin-releasing hormone (GnRH) release. Hence, this study investigated the effects of kisspeptin and GnIH on calcium signaling using immortalized hypothalamic cells (rHypoE-8) as a model. Kisspeptin neurons were loaded with the ratiometric calcium dye (Fura-2 AM, 1 mu mol) and intracellular free calcium ([Ca2+](i)) responses were quantified using digital fluorescence imaging system. Kisspeptin-10 (100, 300, and 1000 nM) caused a significant increase in [Ca2+](i) in rHypoE-8 cells (n = 58, n = 64, and n = 49, respectively, p < 0.001). The kisspeptin receptor antagonist, P234, inhibited the calcium responses to kisspeptin (p < 0.001, n = 32). GnIH (100 and 1000 nM), alone, did not cause any significant change in the mean basal [Ca2+](i) levels in kisspeptin cells, but GnIH attenuated the kisspeptin-evoked [Ca2+](i) transients (n = 47, p < 0.001). This novel findings of [Ca2+](i) signaling in in vitro setting implicate that kisspeptin and GnIH may exert their effects on hypothalamus-pituitary-gonadal (HPG) axis by modulating kisspeptin neurons. These results also implicate that kisspeptin neurons may have an autocrine regulation.
dc.identifier.doi10.1080/10799893.2022.2125014
dc.identifier.endpage613
dc.identifier.issn1079-9893
dc.identifier.issn1532-4281
dc.identifier.issue6
dc.identifier.orcid0000-0002-5551-4880
dc.identifier.orcid0000-0003-0455-4521
dc.identifier.orcid0000-0002-3470-1783
dc.identifier.orcid0000-0003-3755-3015
dc.identifier.pmid36137227
dc.identifier.scopus2-s2.0-85139124098
dc.identifier.scopusqualityQ2
dc.identifier.startpage608
dc.identifier.urihttps://doi.org/10.1080/10799893.2022.2125014
dc.identifier.urihttps://hdl.handle.net/11508/53585
dc.identifier.volume42
dc.identifier.wosWOS:000859116800001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofJournal of Receptors and Signal Transduction
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectKisspeptin
dc.subjectgonadotropin-inhibitory hormone
dc.subjectcalcium signaling
dc.subjectpuberty
dc.titleCrosstalk between kisspeptin and gonadotropin-inhibitory hormone in the silence of puberty: preclinical evidence from a calcium signaling study
dc.typeArticle

Dosyalar